Literature DB >> 4110023

An azobis-arylimidazo-pyridinium derivative: a rapidly acting non-depolarising muscle-relaxant. Clinical study.

B R Simpson, L Strunin, T M Savege, B Walton, E I Foley, M P Maxwell, L A Ross, D M Harris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4110023     DOI： 10.1016/s0140-6736(72)90178-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  Studies on fazadinium bromide (ah 8165): a new non-depolarizing neuromuscular blocking agent.

Authors:  R Hughes; J P Payne; N Sugai
Journal:  Can Anaesth Soc J       Date:  1976-01

2.  Factors limiting the rate of termination of the neuromuscular blocking action of fazadinium dibromide.

Authors:  M B Tyers
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

Review 3.  Proceedings: A new muscle relaxant-AH8165.

Authors:  C E Blogg; T M Savege; J C Simpson; L A Ross; B R Simpson
Journal:  Proc R Soc Med       Date:  1973-10

4.  The effect of ketamine upon depolarizing and non-depolarizing neuromuscular blockade in rabbit.

Authors:  L G Bogdan; S N Glisson; A A El-Etr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

5.  Rapid intubation with fazadinium and suxamethonium.

Authors:  S Mehta; K Lewin; K Fidler
Journal:  Can Anaesth Soc J       Date:  1977-03

Review 6.  Neuromuscular transmission and its pharmacological blockade. Part 1: Neuromuscular transmission and general aspects of its blockade.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

7.  The influence of fazadinium on the potassium efflux produced by succinylcholine.

Authors:  C E Famewo
Journal:  Can Anaesth Soc J       Date:  1981-09

8.  Clinical trial of fazadinium bromide (fazadon).

Authors:  C E Famewo
Journal:  Can Anaesth Soc J       Date:  1981-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.